Inmune Bio (INMB) Selling, General & Administrative (2018 - 2026)
Inmune Bio's Selling, General & Administrative came in at $2.28 million for Q2 2026, up 1.2% from $2.25 million a year earlier and up 5.0% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Selling, General & Administrative (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Inmune Bio reported Selling, General & Administrative of $10.14 million, up 13.9% year-over-year; for FY2025, it came in at $10.26 million, up 8.2% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of 10.2% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $9.48 million in FY2024 (-1.5%), $9.62 million in FY2023 (+3.9%), $9.26 million in FY2022 (+5.3%) and $8.79 million in FY2021 (+39.1%).
- The five-year range for quarterly Selling, General & Administrative is $2.11 million (Q4 2024) to $3.15 million (Q4 2025).
- Year-over-year, Selling, General & Administrative increased in three of the last eight quarters, with growth averaging 1.4%.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q4 2021 (growth of 56.1%), and the weakest in Q2 2025 (a decline of 19.9%).
- Business Quant data shows INMB's Selling, General & Administrative at $2.17 million (Q1 2026), $3.15 million (Q4 2025) and $2.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Inmune Bio | 53.37 Mn | -38.88 Mn | - | 2.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Dec 31, 2025 | 3.15 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 2.11 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.81 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 2.59 Mn |
| Jun 30, 2023 | 2.31 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 2.33 Mn |
| Sep 30, 2022 | 2.38 Mn |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 2.33 Mn |
| Dec 31, 2021 | 2.13 Mn |
| Sep 30, 2021 | 2.52 Mn |
API Access
Inmune Bio Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();